2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
250
Leukemia
186
Lymphoma
137
Leukemia, Myeloid, Acute
103
Burkitt Lymphoma
90
Myelodysplastic Syndromes
79
Lymphoma, Non-Hodgkin
65
Breast Neoplasms
60
Lymphoma, Large B-Cell, Diffuse
59
Leukemia, Lymphocytic, Chronic, B-Cell
49
Lymphoma, Mantle-Cell
47
Hodgkin Disease
47
Graft vs Host Disease
46
Lymphoma, Follicular
45
Leukemia, Myeloid, Accelerated Phase
45
Multiple Myeloma
39
Leukemia, Myeloid, Chronic-Phase
39
Congenital Abnormalities
39
Myeloproliferative Disorders
38
Blast Crisis
38
Leukemia, Myelomonocytic, Chronic
37
Leukemia, Biphenotypic, Acute
35
Recurrence
34
Lymphoma, Large-Cell, Immunoblastic
33
Lymphoma, B-Cell, Marginal Zone
31
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
30
Osteosarcoma
29
Primary Myelofibrosis
27
Neoplasms, Plasma Cell
25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Interventions
pembrolizumab
163
Carboplatin
146
Paclitaxel
125
Cyclophosphamide
94
130-nm albumin-bound paclitaxel
66
Capecitabine
64
Gemcitabine
54
Doxorubicin
50
Albumin-Bound Paclitaxel
45
Taxes
42
atezolizumab
41
Cisplatin
39
sacituzumab govitecan
34
Nivolumab
34
olaparib
32
Epirubicin
32
Specimen Handling
28
Docetaxel
28
eribulin
27
Bevacizumab
26
durvalumab
25
Drug Therapy
25
Biopsy
24
camrelizumab
23
Magnetic Resonance Spectroscopy
22
toripalimab
19
Radiotherapy
17
spartalizumab
16
Everolimus
15
veliparib
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Methotrexate
×
Clear all
NCT00022516
2016-09-16
22-00
ETOP IBCSG Partners Foundation
Phase 3
Completed
1,086 enrolled
10 charts